Angelini

Directed evolution of cross-reactive therapeutic proteins

Cancer and inflammatory diseases are usually multifactorial in nature, involving numerous redundant ligands and receptors that act synergistically. Consequently, treatment with drugs capable of blockade a single pathological molecule is often insufficient to confer cure. The main goal of my project is to engineer cross-reactive proteins capable to interfere with many factors at once providing improved therapeutic efficacy.